Bigbear Pharmaceutical·Medication Guide

• Cabozantinib Pediatric Usual Dose

  Cabozantinib Pediatric Usual DoseThyroid Cancer-DTC(1) IndicationsUse: For the treatment of pediatric patients aged 12 years and older with locally ad···【Read More】

  Update: 2026-07-20Source: Haiou HealthViews: 177

• Adult Usual Dosage of Cabozantinib

  Cabozantinib recommended dosage is closely related to the treated disease and patient age; typically, once daily, with specific dosage strictly follow···【Read More】

  Update: 2026-07-20Source: Haiou HealthViews: 180

• Enasidenib Pharmacokinetics

  Enasidenib Pharmacokinetics1. Absorption: Absolute bioavailability is 57%, with a high-fat meal increasing exposure by 50%. Median time to peak concen···【Read More】

  Update: 2026-07-17Source: Haiou HealthViews: 201

• Enasidenib – Precautions

  Enasidenib, an antineoplastic agent, is a potent and selective inhibitor of isocitrate dehydrogenase-2 (IDH2), indicated for the treatment of relapsed···【Read More】

  Update: 2026-07-17Source: Haiou HealthViews: 171

• Serious side effects of enasidenib

  Enasidenib may cause different side effects during treatment. If you do not have much knowledge about the side effects of enasidenib, it is recommende···【Read More】

  Update: 2026-07-17Source: Haiou HealthViews: 203

• ​Enasidenib Dose Adjustments

  Enasidenib Dose Adjustments1. Hepatotoxicity ManagementBilirubin elevation (more than 3 times the upper limit of normal lasting for 2 weeks or longer,···【Read More】

  Update: 2026-07-17Source: Haiou HealthViews: 198

• Indications for Enasidenib

  Enasidenib adult dosage is usually 100 mg once daily, and should be continued until disease progression or unacceptable toxicity occurs. For specific ···【Read More】

  Update: 2026-07-17Source: Haiou HealthViews: 179

• ​Composition of Anagrelide

  Composition of Anagrelide(1) Anagrelide hydrochloride, USP is a platelet-reducing agent. Its chemical name is 6,7-dichloro-1,5-dihydroimidazo[2,1-b]qu···【Read More】

  Update: 2026-07-17Source: Haiou HealthViews: 179

• ​Anagrelide Adverse Reactions

  Anagrelide Adverse Reactions1、Cardiac disorders: Prinzmetal angina, torsade de pointes.2、Respiratory, thoracic and mediastinal disorders: Interstitial···【Read More】

  Update: 2026-07-16Source: Haiou HealthViews: 177

• Clinical Monitoring for Anagrelide

  Anagrelide capsules, oral, first approved in the United States in 1997. Anagrelide is a platelet-reducing agent indicated for the treatment of thrombo···【Read More】

  Update: 2026-07-15Source: Haiou HealthViews: 180

• ​Anagrelide Side Effect Management for Healthcare Professionals

  Anagrelide Side Effect Management for Healthcare Professionals1. General Adverse EventsVery common (10% or more): edema (20.6%).Common (1% to 10%): pe···【Read More】

  Update: 2026-07-15Source: Haiou HealthViews: 178

• Serious side effects of Anagrelide

  Anagrelide may cause different side effects during treatment. If the patient has limited knowledge about the side effects of Anagrelide, it is recomme···【Read More】

  Update: 2026-07-14Source: Haiou HealthViews: 177

• ​Anagrelide Use in Special Populations

  Anagrelide Use in Special Populations1. Renal ImpairmentIn patients with moderate renal impairment, a single 1 mg dose showed an 8-fold increase in to···【Read More】

  Update: 2026-07-14Source: Haiou HealthViews: 168

• Usual Dosage of Anagrelide for Thrombocythemia in Adults

  Anagrelide dosage and administration are related to age and disease type. For specific use, it is recommended to consult a physician and follow medica···【Read More】

  Update: 2026-07-14Source: Haiou HealthViews: 168

• Osimertinib Pharmacokinetics

  Osimertinib Pharmacokinetics1. Absorption(1) Peak plasma concentration reached approximately 6 hours (range 3–24 hours) after oral administration.(2) ···【Read More】

  Update: 2026-07-14Source: Haiou HealthViews: 166